CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

US RESEARCH ROUNDUP- Clearwater Paper, Molina Healthcare, Qualys

By Reuters News

Oct 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Clearwater Paper, Molina Healthcare and Qualys, on Tuesday.

HIGHLIGHTS

* Bank of Hawaii Corporation BOH.N: KBW cuts to market perform from outperform

* Clearwater Paper Corp CLW.N: RBC cuts target price to $22 from $23

* Molina Healthcare Inc MOH.N: JP Morgan raises target price to $225 from $220

* Ollie'S Bargain Outlet Holdings, Inc. OLLI.O: RBC raises target price to $125 from $124

* Qualys, Inc. QLYS.O: Jefferies raises target price to $235 from $185

Following is a summary of research actions on US companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.


* 1St Source Corporation SRCE.O: Piper Sandler raises target price to $105 from $100

* Associated Banc-Corp ASB.N: Stephens cuts target price to $35 from $36

* Bank of Hawaii Corporation BOH.N: KBW cuts to market perform from outperform

* Bank of Hawaii Corporation BOH.N: KBW cuts target price to $78 from $85

* Bellring Brands, Inc. BRBR.N: JP Morgan cuts target price to $15 from $18

* Business First Bancshares Inc BFST.O: D.A. Davidson raises PT to $39 from $35

* Business First Bancshares Inc BFST.O: Raymond James raises PT to $35 from $34

* Business First Bancshares Inc BFST.O: Stephens raises target price to $38 from $36

* Caci International Inc CACI.N: JP Morgan raises target price to $725 from $715

* Cadence Design Systems, Inc. CDNS.O: JP Morgan raises target price to $420 from $405

* City Holding Co CHCO.O: KBW raises target price to $147 from $145

* City Holding Co CHCO.O: Stephens cuts target price to $125 from $128

* Clearwater Paper Corp CLW.N: RBC cuts target price to $22 from $23

* Clearwater Paper Corp CLW.N: TD Cowen cuts target price to $20 from $21

* Columbia Banking System Inc COLB.O: Piper Sandler raises target price to $37 from $36

* Columbia Banking System Inc COLB.O: TD Cowen raises target price to $33 from $32

* Conocophillips COP.N: Piper Sandler assumes coverage with neutral rating; PT $157

* Constellation Energy Corp CEG.O: TD Cowen raises target price to $374 from $368

* Coreweave, Inc. CRWV.O: Raymond James cuts target price to $75 from $125

* Delek US Holdings Inc DK.N: Piper Sandler assumes coverage with neutral rating; PT $90

* EQT Corporation EQT.N: Gerdes Energy Research cuts target price by $1 to $78

* Flagstar Bank, National Association FLG.N: Stephens cuts target price to $11 from $13

* Glacier Bancorp Inc GBCI.N: Stephens raises target price to $54 from $53

* Hbt Financial Inc HBT.O: D.A. Davidson raises target price to $39 from $37

* Hbt Financial Inc HBT.O: Piper Sandler raises target price to $40 from $39

* HF Sinclair Corporation DINO.N: Piper Sandler assumes coverage with overweight rating; PT $152

* Kinder Morgan, Inc. KMI.N: Scotiabank raises target price to $34 from $32

* Lakeland Financial Corp LKFN.O: KBW raises target price to $64 from $63

* Lifestance Health Group, Inc. LFST.O: Jefferies raises target price to $15.50 from $15

* Match Group MTCH.O: TD Cowen raises target price to $52 from $45

* Mid Penn Bancorp Inc MPB.O: Piper Sandler cuts target price to $40 from $42

* Moelis & Company MC.N: JP Morgan cuts target price to $68 from $70

* Molina Healthcare Inc MOH.N: JP Morgan raises target price to $225 from $220

* Nb Bancorp Inc NBBK.O: KBW cuts target price to $24 from $25

* Newmont NEM.N: Scotiabank cuts target price to $148 from $149

* Occidental Petroleum Corp OXY.N: Piper Sandler assumes coverage with neutral rating; PT $69

* Ollie'S Bargain Outlet Holdings, Inc. OLLI.O: RBC raises target price to $125 from $124

* Oric Pharmaceuticals, Inc. ORIC.O: Wedbush cuts target price to $14 from $17

* Paycom Software, Inc. PAYC.N: Jefferies raises target price to $300 from $160

* PBF Energy Inc. PBF.N: Piper Sandler assumes coverage with neutral rating; PT $94

* Primis Financial Corp FRST.O: Stephens cuts target price to $19 from $20

* Qualys, Inc. QLYS.O: Jefferies raises target price to $235 from $185

* Rapid7, Inc. RPD.O: Jefferies raises target price to $16 from $12

* Rithm Capital Corp. RITM.N: KBW raises target price to $13 from $12.5

* River City Bank RCBC.O: Raymond James raises target price to $60 from $56

* Sierra Bancorp BSRR.O: D.A. Davidson raises target price to $48.50 from $47

* Surgery Partners, Inc. SGRY.O: RBC cuts to sector perform from outperform; ups PT to $23.5 from $19

* Tenable Holdings, Inc TENB.O: Jefferies raises target price to $45 from $30

* Tesla Inc TSLA.O: Daiwa Capital Markets raises target price to $390 from $345

* US Physical Therapy Inc USPH.N: Jefferies raises target price to $101 from $96

* Valley National Bancorp VLY.O: Stephens raises target price to $17.5 from $16.5

* Verizon VZ.N: Morgan Stanley cuts target price to $50 from $52

* Verizon VZ.N: TD Cowen cuts target price to $55 from $56

* Weyerhaeuser Company WY.N: CIBC cuts target price to $25.00 from $30.00

* Weyerhaeuser Company WY.N: D.A. Davidson cuts target price to $27 from $31

* Xencor, Inc. XNCR.O: Piper Sandler raises target price to $40 from $33

* Xencor, Inc. XNCR.O: RBC raises target price to $43 from $20

* Xencor, Inc. XNCR.O: Truist Securities raises target price to $40 from $29

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.